A next-generation CD33-directed ADC for AML
The future of immunotherapy in multiple myeloma
Hearn Cho et al.
How can standard risk multiple myeloma (MM) patients be cured?
MUK Nine b: OPTIMUM, paving the way to effectively treat newly diagnosed high-risk MM
Why are nurses important in the patient journey?